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Observing the endogenous abundance, localization,
and dynamics of proteins in mammalian cells is
crucial to understanding their function and behavior.
Currently, there is no systematic approach for the
fluorescent tagging of endogenous loci. Here, we
used Cas9-catalyzed DNA breaks, short homology
arms, and a family of donor plasmids to establish
endogenous Fluorescent tagging (eFlut): a low-cost
and efficient approach to generating endogenous
proteins with fluorescent labels. We validated this
protocol on multiple proteins in several cell lines
and species and applied our tools to study the cell-
cycle inhibitor CDKN1A in single cells. We uncover
heterogeneity in the timing and rate of CDKN1A in-
duction post-DNA damage and show that this vari-
ability is post-transcriptionally regulated, depends
on cell-cycle position, and has long-term conse-
quences for cellular proliferation. The tools devel-
oped in this study should support widespread study
of the dynamics and localization of diverse proteins
in mammalian cells.
INTRODUCTION
Studying the endogenous localization, abundance, and behavior
of proteins is crucial to understanding their regulation and func-
tion. Generation of endogenously tagged genes by random
insertion of fluorescent proteins into the genome of mammalian
cells has given important insights into cellular dynamics and
signaling (Sigal et al., 2006; Cohen et al., 2008; Cohen-Saidon
et al., 2009), as have targeted insertions with large homology re-
gions in embryonic stem (ES) cells (Lengner et al., 2007) or using
adenoviruses (Shaltiel et al., 2014). In budding yeast, systematic
‘‘tagging’’ of endogenous genes with fluorescent proteins has
enabled proteome-wide surveys of protein localization (Huh
et al., 2003), abundance (Ghaemmaghami et al., 2003), and
response to stimuli (Tkach et al., 2012). More generally,
homologous recombination with short DNA homology regions
(40–60 bp) and a set of template plasmids containing genetic1800 Cell Reports 14, 1800–1811, February 23, 2016 ª2016 The Authmarkers for gene replacement, tagging, and modification give
budding yeast part of its genetic power.
Similar techniques have not generally been applicable to
mammalian genomes outside of mouse ES cells, mainly due to
weaker homology-directed repair capacity. With the advent of
CRISPR/Cas9 technology, which enables precise cutting of the
genome, it may now be possible to develop efficient homol-
ogy-directed tagging approaches for multicellular organisms,
including mammalian cells. Indeed, groups have published
tagging of specific endogenous proteins in Drosophila (Bo¨ttcher
et al., 2014) and mammalian cells (Park et al., 2014), using
CRISPR toolsets. However, there has not been a systematic
approach to developing a common plasmid set that allows flex-
ible tagging or modification of the genome with a range of fluo-
rescent protein colors and variants. Here, we established such
a systematic approach and used it to tag multiple fluorescent
proteins to key signaling proteins in mammalian cells, including
Erk2, beta-catenin, and RelA. Further, we take advantage of viral
self-cleaving sequences to generate transcriptional reporters
that are transcribed and translated with the protein of interest
but cleaved off to form a separate polypeptide, allowing separa-
tion of transcriptional and post-translational regulation. As in
yeast, we use PCR primers whose 50 ends have40 nt of homol-
ogy to the target gene sequences and 30 ends that anneal to our
plasmid cassettes (Baudin et al., 1993; Longtine et al., 1998).
This minimal homology results in limited efficiency for tagging
(0.01%–1%), but selection with antibiotic markers allows for
rapid enrichment of modified cells. Our endogenous Fluorescent
tagging (eFlut) toolset allows for modification of loci with a range
of markers and reporters, using a minimum of PCR primers.
Tagging of endogenous loci with fluorescent proteins, as
opposed to adding exogenous reporters, minimizes the pertur-
bation when tracking cellular components. This is particularly
relevant for studying the cell cycle, where a delicate balance of
cyclins, cyclin-dependent kinases (CDKs), and CDK inhibitors
orchestrates cell-cycle entry, exit, and progression. A crucial
component of this network is CDKN1A (p21), a DNA-damage-
induced CDK inhibitor that regulates cell-cycle arrest after
DNA damage (Dulic et al., 1994) and also plays a role in regu-
lating quiescence and S-phase entry in the unperturbed cell
cycle (Overton et al., 2014). Using eFlut, we endogenously
tagged alleles of CDKN1A in a range of different cell lines
and quantified the unperturbed and DNA-damage-responsiveors
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Figure 1. The eFlut Collection of Plasmids for PCR Amplification-
Based Tagging of Endogenous Genes
(A) Diagram of the C-terminal fusion constructs (1A) with pairwise combination
of three fluorescent proteins (FP) and selective markers (SM).
(B) Diagram of the transcriptional reporters (1B) containing a T2A viral cleavage
sequence between the ORF and the fluorescent protein.
(C) Diagram of the N-terminal tagging construct (1C). F1 and R1 indicate PCR
primers for C-terminal tagging; F2 and R2 indicate PCR primers for N-terminal
tagging.
See also Supplemental Experimental Procedures and Table S1.kinetics of CDKN1A in single cells. Our analysis revealed that, in
response to DNA damage, CDKN1A transcription is highly syn-
chronous in a population, while CDKN1A-protein levels show
distinct and complex dynamics linked to the cell-cycle phase.
These results confirm that endogenous tagging of mammalian
genes will enable high time resolution measurements of endog-
enous proteins’ abundance and localization in many contexts,
which is essential for understanding their regulation and function
in mammalian cells.
RESULTS
eFlut: A Toolset for Mammalian Gene Tagging
We began by constructing a series of plasmids that allow for
amplification with common PCR primers for C-terminal tagging
(Figure 1A; Figure S1). We decided to focus on the C terminus,
as 2 decades of experience in yeast suggest that the majority
of proteins are unperturbed by such a fusion. These plasmids
encoded a yellow fluorescent protein (YFP; mVenus), a CFP
(mCerulean), or a red fluorescent protein (RFP; mKate2), fol-
lowed by a viral cleavage tag and a selectable antibiotic marker
(neomycin, blasticidin, or hygromycin). These plasmids (termed
1A throughout the paper) allow for C-terminal tagging and selec-
tion of in-frame integrations with antibiotics without introducing
terminators or other RNA elements and, therefore, do not require
additional use of recombinases to maintain near-endogenous
30 UTR structure. Note that this set of constructs relies on the
endogenous promoter to express the antibiotic marker.
In some circumstances, instead of tagging the endogenous
protein, it is desirable to measure the transcription from theCell Rloci without attaching a large fluorescent tag to the protein of in-
terest. To accommodate this, we constructed a set of plasmids
that contain a T2A cleavage tag between the loci of interest and
the fluorescent protein and also attached an NLS-PEST cassette
(Figure 1B). This causes an endogenous protein to be expressed
and translated with a short additional peptide sequence from the
T2A element and a separate polypeptide expressing the fluores-
cent protein with an NLS-PEST, which aids in quantification and
time dynamics of the reporter. These constructs (termed 1B
throughout the paper) allow for tracking the transcription and
translation of an endogenous protein without the influence of
post-translational regulation (Figure 1B).
Not all proteins are compatible with C-terminal tagging. For
example, tail anchor proteins fail to correctly localize whenC-ter-
minal sequences are appended. To develop an N-terminal-
tagging plasmid, we constructed an allele that contained a Neo
marker followed by a T2A cleavage tag and an EGFP protein
(termed 1C throughout the paper). This combination permits
tagging of endogenous loci at the N terminus and selection
with neomycin without disruption of the underlying open reading
frame (ORF) (Figure 1C). In the future, we expect to expand the
markers and colors available for translational tags and N-termi-
nal fusions.
Initial Validation of the eFlut Toolset
To validate the set of C-terminal-tagging plasmids (1A), we first
applied them to the CDK inhibitor, CDKN1A, as it previously
was shown that C-terminal tags do not disrupt CDKN1A function
(Overton et al., 2014). Using a Cas9 plasmid (Ran et al., 2013)
and a guide RNA (gRNA) designed to target the stop codon re-
gion of CDKN1A, we transfected a mixture of Cas9/gRNA
plasmid and PCR product from the YFP-P2A-NEO plasmid into
MCF7 cells. In the case of CDKN1A, the gRNA stretched across
the stop codon and was, therefore, destroyed when the final
tagged recombination product was obtained. To tag loci without
such a ‘‘self-inactivating’’ gRNA sequence. it is necessary to
introduce additional mutations into the locus to destroy the
gRNA binding site (see the Supplemental Experimental Proce-
dures for detailed protocol). We obtained single-cell clones
and used PCR to confirm an increase in product size, indicating
that CDKN1A tagging was successful (Figures 2A and 2B). We
also sequenced the PCR product for the CDKN1A-YFP junction
and found that, as expected, the protocol led to a clean fusion of
the YFP to themost C-terminal codon of CDKN1A (Figure 2B). To
further verify CDKN1A tagging with the fusion (1A) and transcrip-
tional (1B) constructs, we performed a western blot of these cells
before and after treatment with Nutlin3A, a small molecule that
activates p53, the upstream regulator of CDKN1A. Nutlin3A
treatment led to the induction of CDKN1A in the wild-type (WT)
parental cells, the CDKN1A-YFP fusion in the knockin cell line,
and both the endogenous CDKN1A and the GFP-NLS in the
line expressing the transcriptional reporter 1B (Figure 2C). These
results suggest that the 1A and 1B constructs can successfully
tag proteins with the expected molecular products.
Having validated the general short-homology-arm approach
to gene tagging, we then systematically tested the plasmids
from our collection. Testing the gene-fusion plasmids, after se-
lection, we obtained a mixed population of cells, roughly half ofeports 14, 1800–1811, February 23, 2016 ª2016 The Authors 1801
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Figure 2. The eFlut Vectors Enable Efficient
Tagging of CDKN1A with Combinations of
Colors and Markers
(A) Schema of endogenous and engineered
loci (exons are indicated by E2 or E3 and a thick
line).
(B) PCR amplification of genomic DNA from un-
engineered MCF7 cells or cell lines engineered
with CDKN1A tagged with YFP (1A plasmid) or
T2A-GFP (1B plasmid). All three primers
diagrammed in (A) (F10, R10, R20) were used
in each reaction (see Table S2 for primer
sequences).
(C) MCF7 cells with CDKN1A tagged were
cloned from single cells treated with Nutlin3A
for 8 hr to induce p21 expression and were
subsequently lysed and probed for CDKN1A
and GFP expression. The WT MCF7 cells show
CDKN1A expression 8 hr after Nutlin3A treat-
ment, but no GFP signal. The CDKN1A-YFP cell
line shows a CDKN1A-YFP fusion protein, which
runs at the expected 48 kDa. The CDKN1A-
T2A-GFP-NLS clone (expressing the transcrip-
tional reporter 1B) shows endogenous CDKN1A
running at its WT molecular weight and an
additional GFP-NLS species induced by Nut-
lin3A. Asterisk represents a non-specific band
for the GFP antibody.
(D) CDKN1A was tagged in MCF7 cells
with the listed vectors and measured before and
5 hr after induction of DNA breaks by NCS
treatment.
(E) CDKN1A was tagged with T2A cleaved GFP-
NLS sequences (plasmid 1B) and imaged before
and 5 hr after NCS treatment.
(F) MCF7 cells with an N-terminally tagged BBC3
(PUMA, transcript isoform NM_014417, plasmid 1C) before and 8 hr after induction of the BBC3 transcriptional activator p53 by Nutlin3A.
(G) MCF7 cells with CDKN1A tagged with both YFP and RFP (1A plasmids) show a tight correlation 8 hr after DNA damage induced by NCS.
See also Table S2.which showed weak nuclear fluorescence. Within 4 hr of DNA
damage, we observed a substantial increase in fluorescence,
as anticipated for a tagged CDKN1A allele (el-Deiry et al.,
1994; Figure 2D). Similar results were obtained with all nine 1A
plasmids (Figure S2A).
Next, we checked the fluorescence signal from a cell line ex-
pressing the CDKN1A translational reporter (1B). As anticipated,
this cell line showed weak fluorescence in the absence of DNA
damage and an increase in nuclear fluorescence after DNA
damage, as did cells tagged with the RFP or CFP versions of
the transcriptional reporter 1B (Figures 2E and S2B). Finally, to
test the N-terminal cassette (1C plasmid), we tagged the tail an-
chor protein BBC3 (PUMA) with GFP. Expression of GFP-PUMA
increased in response to stabilization of its transcriptional acti-
vator p53 by Nutlin3A and appeared mitochondrial, as expected
(Figure 2F; Wilfling et al., 2012; Zhang et al., 2009).
In some circumstances, single-allele tagging may be desirable
if, for example, the tagged protein ismildly hypomorphic. In other
cases, following all molecules of a given protein may be critical.
To compare the frequency of homozygous and heterozygous
knockins, we performed PCR checks on single-cell-derived
clones from CDKN1A tagging of the aneuploidy MCF7 and1802 Cell Reports 14, 1800–1811, February 23, 2016 ª2016 The Authdiploid NIH 3T3 cell line. We observed that 20%–30% of clones
in each cell line show only the tagged species by PCR (4/18 for
NIH 3T3 and 7/24 for MCF7; Figures S3A and S3B). Tagging of
multiple alleles can occur by two ways; homologous recombina-
tion from a different donor oligo in each locus or sequential modi-
fication of a single locus followed by templated recombination
onto the second locus. To determine whether different DNA
donors can contribute to gene tagging at the same locus,
we tagged CDKN1A in MCF7 cells using a mixed-donor popula-
tion of YFP and RFP. Treating the polyclonal population, we
observed that 4% of the cells show both colors of CDKN1A
after DNA damage and subsequently identified 3/41 clones
expressing both colors, compared to 12% (14/41) and 14%
(10/41) expressing a single color (RFP or YFP, respectively),
showing that multiple donors can recombine in the same cell
(Figures S3C–S3E). The approach to obtaining multicolor-
tagged alleles is a potentially useful tool for studying the stochas-
ticity of gene expression and allele specific expression patterns.
For a clone expressing both a CDKN1A-YFP tag and a CDKN1A-
RFP tag, using the 1A plasmids, we observed a strong correla-
tion between expression of the two alleles after DNA damage
(r = 0.7684; Figure 2G).ors
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Figure 3. The eFlut Toolset Can Be Used for
Tagging Various Genes in Different Cell
Lines and Species
(A) The six listed proteins were tagged with YFP in
U2OS cells (CTNNB1) or MCF7 (all others), imaged
in basal conditions and under the following stimu-
lation: ERK2, serum; FoxO1, AZD8055; Mdm2,
NCS; CTNNB1, CH99021; RelA, tumor necrosis
factor (TNF); and TP53, NCS (see Experimental
Procedures for exact concentrations and timing).
(B) The cell-cycle factors PCNA and GMNN were
tagged with YFP (Plasmid 1A) in MCF7 cells and
single cells tracked through the cell cycle by mi-
croscopy. Arrows indicate tracked cells at the
indicated cell-cycle phases.
(C) Two human lines (UACC257 and HCT116) and
one mouse line (NIH 3T3) were tagged at the
CDKN1A locus with YFP (using the C-terminal
fusion plasmid 1A) and imaged before or 6 hr after
DNA breaks induced by NCS treatment.
(D) Human (A549), dog (MDCK), and mouse (HEP-
A1C1C7) cell lines were tagged at the TP53 locus
with YFP (using plasmid 1A) and imaged before and
2 hr after NCS treatment.
(E) MCF7 cells expressing RelA tagged with YFP
(using plasmid 1A) were exposed to TNFa and
imaged for 8 hr. YFP images with 15 min between
frames are shown, as is quantification of nuclear
RelA-YFP for three cells. The mean autocorrelation
of RelA traces (n = 10) shows a peak at 90 min.
(F) MCF7 cells expressing p53-YFP were imaged
for 2 hr and then were exposed to the DNA-
damaging agent NCS and imaged for an additional
22 hr. YFP images with 1 hr between frames are
shown, as is quantification of the p53-YFP signal
from three cells. The mean autocorrelation of p53
traces (n = 10) show a peak at 5 hr.
(G) MCF7 cells with YFP knocked into the GMNN
locus (using the C-terminal fusion plasmid 1A)
and co-expressing exogenously expressed GMNN
(1-110)-CFP were tracked over 48 hr. The endog-
enous and exogenous GMNN reporters show
similar profiles across the cell cycle and are rapidly
depleted following cytokinesis. Cellular divisions
are indicated by a dashed line.
(H) Addition of a fluorescent protein tag to an
endogenous protein allows regulation of the
endogenous protein. Doxycycline (Dox)-inducible
promoter drives an Anti-GFP nanobody fused to an E3 ligase component. Addition of doxycycline results in depletion of a PCNA fused to YFP in MCF7 cells. NT,
no treatment.
(I) Quantification of PCNA-YFP degradation in single cells following doxycycline treatment (n = 16). Faint lines represent PCNA-YFP levels in single cells. The
mean is shown in bold.Multiple Genes Can Be Tagged Using eFlut in Various
Cell Lines and Species
Next, we tested how general the eFlut toolset is by fluorescently
tagging nine additional proteins in their endogenous locus
(MDM2, TP53, FOXO1, RelA, Erk2, CTNNB1, GMNN, PCNA,
and KI67) with the C-terminal fusion YFP-NEO plasmid (1A).
We found that each tagged protein retained its expected locali-
zation and response to stimulus or cell-cycle progression (Fig-
ures 3A and 3B; Figure S4; Lahav et al., 2004; Tay et al., 2010;
Calnan and Brunet, 2008; Costa et al., 2006; Chen et al., 2014;
Sakaue-Sawano et al., 2008; Celis and Celis, 1985; van Dieren-Cell Rdonck et al., 1989). We further validated a subset of lines by
western blot and genomic PCR and observed an expected
GFP-protein fusion weight and PCR products (Figures S3F and
S3G). Two other proteins (ATM and P38) did not generate suc-
cessful tags. In each case, we used only a single gRNA, making
it possible that testing of further gRNA, or slightly modified or
longer homology regions, would allow for tagging of even these
refractory genes. In addition, we applied our toolset to six addi-
tional cell lines, tagging CDKN1A or p53 in three human lines
(HCT116, A549, and UACC257), two mouse lines (NIH 3T3 and
HEPA1C1C7), and one dog line (MDCK) (Figures 3C and 3D).eports 14, 1800–1811, February 23, 2016 ª2016 The Authors 1803
These results suggest that the eFlut toolset haswide applicability
across cell lines, species, and proteins.
To further validate that the endogenous fusions generated by
eFlut behave similarly to previously described constructs, we
quantified the dynamics of the transcription factors RelA and
TP53. The dynamics of these proteins have been well studied;
they both exhibit highly stereotyped oscillations that require tran-
scriptional functionality and precise degradation kinetics and,
therefore, represent a stringent test of the tagged proteins func-
tionality. Both TP53-YFP and RelA-YFP (using the C-terminal
fusion plasmids 1A) exhibited normal response to DNA damage
and tumor necrosis factor a (TNFa) treatment, showing oscilla-
tions with periods of 5 hr and 90 min, respectively (Figures 3E
and 3F; Lahav et al., 2004; Tay et al., 2010). We also established
a cell line expressing the cycle-dependent protein Geminin
(GMNN) fused to YFP (using the C-terminal fusion plasmids
1A) and also expressing the widely used GMNN (1-110)-CFP
‘‘FUCI’’ cell-cycle-tracking construct (Sakaue-Sawano et al.,
2008). We observed near-identical dynamics of the endogenous
GMNN-YFP and FUCI transgene, with accumulation in the S/G2
phase and depletion after cytokinesis (Figure 3G). Note that the
endogenous tag that we established exhibited less variability in
expression level between cell cycles. We concluded that endog-
enous tagging using our eFlut toolset does not disrupt the dy-
namics of p53, RelA, and Geminin.
Another useful purpose for tagging endogenous genes is
to use the tag as a handle for manipulating protein levels. We
obtained an anti-GFP nanobody fused to an E3-ligase compo-
nent (deGradFP, NSlmb-vhhGFP4) that has been used for
depletion of GFP-tagged proteins in Drosophila and mammalian
cells (Caussinus et al., 2012), placed it under a doxycycline-
inducible promoter, and expressed it in cells with the PCNA-
YFP knockin gene (Figure 3H). The addition of doxycycline
resulted in the depletion of PCNA-YFP over 48 hr, validating
that this approach is applicable to manipulating tagged genes
(Figure 3I).
A Tagged CDKN1A Is Regulated by the Cell Cycle
and p53
Next, we investigated the utility of eFlut technology for studying
cell-cycle regulation of CDKN1A. We quantified CDKN1A-YFP,
as cells progressed through the cell cycle, by time-lapse micro-
scopy over 48 hrs (roughly, two cell cycles). In both MCF7 and
NIH 3T3 cells, CDKN1A oscillated with the cell cycle, rising in
the G2-M-G1 phase and rapidly degrading as cells entered the
S phase, as estimated by cell division time and in silico alignment
of single cells (Figures 4A and 4B; Figure S5; Movies S1 and S2;
Loewer et al., 2010). Note that theCDKN1A behavior and cell-cy-
cle timing varies substantially between individual cells (Fig-
ure 4B). The source of this heterogeneity is still unknown and
may represent intrinsic random variations or the presence of
an unmeasured underlying factor. To further verify the relation-
ship between CDKN1A degradation and the cell cycle, we
compared the accumulation and degradation of GMNN-YFP
and CDKN1A-CFP in a cell line expressing both tags. As ex-
pected, we observed that degradation of CDKN1A-YFP pre-
ceded GMNN-YFP accumulation, which is known to occur in
the S phase (Figure 4C; Bornstein et al., 2003).1804 Cell Reports 14, 1800–1811, February 23, 2016 ª2016 The AuthInMCF7 cells, we noted that CDKN1A levels often rose sharply
in theG1 phase. This sharp increase resembled the spontaneous
pulses of p53 that we have previously observed in the G1 phase
(Loewer et al., 2010). To test whether p53 contributed to
CDKN1A accumulation in the G1 phase, we compared
CDKN1A-YFP accumulation in WT cells to that in cells in which
p53 was depleted by a retroviral short hairpin RNA (shRNA)
construct. We found a CDKN1A pulse in the G1 phase in WT
p53 cells, but not in shp53 cells, supporting a role for p53 in trig-
gering CDKN1A pulses in the G1 phase (Figure 4D). To further
quantify the relationship between p53 and CDKN1A pulses in
the G1 phase, we constructed a cell line expressing both a
p53-YFP reporter and a CFP-tagged CDKN1A (plasmid 1A). Im-
aging these cells as they passed through the cell cycle, we
observed that the sharp increases in CDKN1A-CFP signal were
typically preceded by a pulse of p53-YFP (Figures 4E and 4F;
Movie S3). Note that the small simultaneous peaks in p53 and
CDKN1A at mitosis result from cell rounding and autofluores-
cence during division.
Interestingly, not all p53 pulses led to CDKN1A pulses, and
evensister cells,which show identical bursts of p53activity, often
showdivergentCDKN1Aaccumulation (Figure 4G). To determine
whether specific aspects of the p53 pulse predict the CDKN1A
response, we quantified p53 and CDKN1A in >100 cells and
computationally identified all spontaneousp53peaks andsubse-
quent CDKN1A dynamics. In silico synchronization of CDKN1A
traces to the peak of the p53 pulse revealed that p53 induction
is, indeed, followed by an increase in CDKN1A level on average
(Figure 4H). In addition, we have observed a moderate (R =
0.36) but significant (p < 0.05) association between p53-YFP
fold change and CDKN1A-T2A-CFP transcriptional reporter (Fig-
ure 4I). We tested other quantitative features of p53 dynamics,
including its integral, amplitude, and pulse width, but did not
observe increased predictive power (Figure S6). Collectively,
these experiments suggest that the sharp accumulation of
CDKN1A observed in the G1 phase results from p53 induction.
The observation that not all p53 pulses are productive in acti-
vating CDKN1A suggest additional mechanisms that buffer
against p53 activity in non-damaged proliferating cells.
The Timing of CDKN1A Induction Post-DNA Damage
Depends on the Cell-Cycle Phase
In response to DNA damage, CDKN1A is induced by p53 and
leads to cell-cycle arrest. To quantify the dynamics of CDKN1A
in response to DNA damage, we imaged CDKN1A-RFP cells af-
ter DNA double-strand breaks induced by the radiomimetic drug
neocarzinostatin (NCS). Interestingly, although CDKN1A-RFP
levels increased in all cells, the timing and rate of the increase
were heterogeneous (Figure 5A; Movie S4). Specifically, some
cells immediately induced CDKN1A, whereas in others, we
observed CDKN1A protein expression only R10 hr post-DNA
damage (Figure 5A). To verify the heterogeneous behavior of
CDKN1A after DNA damage, we performed immunofluores-
cence on the endogenous CDKN1A protein in fixed cells, which
allows rapid measurements and computational analysis of
thousands of cells. Endogenous CDKN1A protein showed a
long-tailed distribution of expression levels after DNA damage
(Figure 5B), consistent with the large variation in the dynamicsors
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Figure 4. CDKN1A Oscillation during the Cell Cycle Are Driven by Rapid Degradation in S Phase and p53
(A) MCF7 cells expressing CDKN1A tagged with YFP at the endogenous locus were tracked over 48 hr. Divisions are indicated by a dashed line.
(B) A histogram showing the distribution of times between mitosis and the loss of CDKN1A signal (n = 58) in MCF7 cells. The peak at 8 hr is consistent with entry
into the S phase in these cells (Loewer et al., 2010).
(C) Cells expressing GMNN-YFP and CDKN1A-CFP from the endogenous loci were imaged over 36 hr. Depletion of CDKN1A occurs shortly before GMNN-YFP
accumulation, consistent with CDKN1A degradation in the early S phase. norm., normalized.
(D) Cells expressing CDKN1A-YFP were analyzed for YFP accumulation in the G1 phase measured in WT (n = 88) or p53 depleted (n = 54) cells. Only WT cells
show an accumulation of CDKN1A in the G1 phase. Faint traces represent examples from single cells. Bold traces represent the averaged behavior.
(E) MCF7 cells expressing p53-YFP and CDKN1A-CFP were imaged for 48 hr. Single-cell traces of two cells are shown with pulses of p53 (blue) preceding
CDKN1A (yellow). Dashed lines represent division times.
(F) Quantification of the distributions of times between the peak of a p53 pulse and the subsequent CDKN1A expression (n = 42 cells).
(G) Not all p53 pulses result in CDKN1A expression. A pair of sister cells is shown; both show p53 pulses after mitosis (blue), but only one of which subsequently
activates CDKN1A (yellow). Asterisks indicate the sister cells that are followed in the traces below.
(legend continued on next page)
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of the CDKN1A-RFP tagged in live cells (Figure 5A). To test
whether the variation in the timing of CDKN1A induction post
damage is due to variation in p53, we examined p53 levels in
response to DNA damage. We observed a strong and homoge-
nous induction of p53 after DNA damage (Figure 5C), indicating
that other cellular factors are responsible for the variation in
CDKN1A levels post-damage.
Next, we asked whether the different CDKN1A kinetics in
different cells result from stochastic activation of the CDKN1A
promoter. We measured the DNA-damage response of a cell
line with the T2A-GFP-NLS transcriptional reporter (plasmid
1B) knocked into the endogenous locus. In this construct, the
GFP is cleaved off CDKN1A, eliminating post-translational regu-
lation. Consistent with the uniform expression of p53 (Figure 5C),
the cleaved fluorophore was induced homogenously across
cells in response to DNA damage (Figure 5D), implicating that
post-translational regulation of CDKN1A introduces population
heterogeneity (Figures 5A and 5B). We verified this conclusion
with single-molecule fluorescence in situ hybridization (smFISH)
for the CDKN1A transcript before and after DNA damage, noting
a strong and uniform increase in CDKN1A mRNA levels after
DNA damage (Figure 5E; Raj et al., 2008). Comparing the behav-
iors of the protein fusion (using plasmid 1A) and transcriptional
CDKN1A (using plasmid 1B) reporters in time-lapse microscopy,
we note a rapid and fairly uniform increase in the transcriptional
reporter compared to a much more heterogeneous response of
the protein fusion (Figure 5F; Movies S4 and S5). Taken together,
these results indicate that the variation in CDKN1A expression
emerges from post-translational regulation and not from tran-
scriptional heterogeneity.
Next, we asked whether cell-cycle position can explain the
variation in accumulation of CDKN1A after DNA damage. To
test this, we compared the time elapsed since cell division to
the CDKN1A-RFP expression 4 hr after DNA damage. We
observed that cells that have recently divided (within 8 hr before
damage), or divided long before damage (>16 hr), accumulate
CDKN1A, whereas cells that divided between 8 hr and 16 hr
before damage (which are likely in S phase at the moment of
damage) show negligible accumulation of CDKN1A protein (Fig-
ures 5G and 5H). These results suggest that the cell-cycle phase
in which damage occurs plays a major role in determining the ki-
netics of CDKN1A protein accumulation. As CDKN1A accumula-
tion has been implicated in resistance to apoptosis (Wang and
Walsh, 1996; Maddocks et al., 2013), regulation of CDKN1A
accumulation is one potential mechanism by which cell-cycle
position could influence response to a range of cytotoxic
treatments.
CDKN1A Expression after DNA Damage Predicts
Reduced Proliferation
To test the consequences of CDKN1A induction and, specif-
ically, whether the diversity of CDKN1A expression after DNA(H) Spontaneous pulses of p53 induce CDKN1A accumulation. MCF7 cells expre
peaks were computationally extracted, and CDKN1A accumulation was measur
(I) Cells expressing p53-YFP and either CDKN1A-CFP (plasmid 1A, n = 59) or CDK
and subsequent CDKN1A accumulation were extracted. A mild association (R = 0
T2A-CFP reporter.
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a cell line expressing the proliferation marker ki67 tagged with
YFP and CDKN1A tagged with RFP (plasmids 1A). We found
that, as predicted, in the absence of DNA damage, most cells
are ki67-YFPhigh and CDKN1Alow. After DNA damage, CDKN1A
was induced in a fraction of cells, and ki67 expression was lost
in those same cells (Figure 6A;Movie S6). We quantified the tran-
sition from ki67-YFPhigh/CDKN1Alow to a ki67-YFPlow/CDKN1A-
high and verified that after DNA damage, cells lose proliferative
markers and increase CDKN1A expression (Figures 6B and
6C). Then, we asked whether early CDKN1A expression could
predict subsequent loss of ki67 and proliferative potential by
quantifying CDKN1A-RFP expression 5 hr after DNA damage
and ki67 levels 24 hr after damage (Figure 6D). We observed
that early expression of CDKN1A does, indeed, predict loss of
proliferative potential, suggesting that early, cell-cycle-regulated
accumulation of CDKN1A (Figures 5G and 5H) results in long-
term fate-determining consequences for the cell.
DISCUSSION
The recent availability of Cas9 reagents has allowed many
groups to perform low- to high-throughput gene-knockout ex-
periments. Here, we developed a novel plasmid set and used
PCR with short DNA oligos to introduce fluorescent tags into
various proteins in the genome ofmultiple cell lines. The flexibility
of our eFlut toolset will complement the existing Cas9 technol-
ogy and make gene tagging in mammalian cells a more stan-
dardized, transparent, and general approach.
We suggest that short-homology-mediated recombination,
whichwe apply here to tag genes, will be extended to othermod-
ifications, such as promoter swaps and gene replacement.
Further, we expect that, as with the yeast-tagging plasmid col-
lections, there will be substantial room to optimize and extend
these reagents with improved linkers, fluorophores, andmarkers
(Sheff and Thorn, 2004). We show that the toolset described here
enables rapidmodification and observation of proteins in several
cell lines and expect that incorporating additional approaches to
improve homologous recombination efficiency or delivery of the
Cas9/gRNA complex will extend the flexibility of these tools
further (Yu et al., 2015). Finally, the low cost of this approach
and relatively limited labor involved may enable large collections
of tagged proteins to be assembled.
With regard to CDKN1A, we observe cell-cycle regulation that
likely relies on the regulation of protein stability (Bornstein et al.,
2003; Overton et al., 2014) and also transcriptional regulation
by p53, the activity of which, we find, often precedes an increase
in CDKN1A expression. Consistent with previous work, we
observed that not all p53 pulses induce CDKN1A expression
(Loewer et al., 2010), and defining the characteristics of the
p53 kinetics or modifications that result in productive CDKN1A
expression is an unanswered question.ssing CDKN1A-CFP and p53-YFP were imaged over 48 hr. Spontaneous p53
ed and averaged (n = 105 cells, 59 peaks).
N1A-T2A-CFP (plasmid 1B, n = 93) were imaged for 48 hr. The p53 fold change
.36) was observed between p53 fold change and the transcriptional CDKN1A-
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Figure 5. The Timing and Rate of CDKN1A Induction in Response to DNA Damage Depend on the Cell Cycle
(A) Schematic of signal transduction in response to DNA damage, showing CDKN1A induction through transcriptional activation by p53. MCF7 cells expressing
CDKN1A-YFP were exposed to DNA damage and traced over time. Some cells immediately accumulated CDKN1A, whereas others show a delay.
(B) Expression of the CDKN1A endogenous protein and reporter show heterogeneous abundance across single cells. Images: MCF7 cells expressing CDKN1A
tagged with RFP (1A) were imaged before and after (4 hr) DNA damage. Histograms: distribution of endogenous CDKN1A quantified by immuofluorescence. The
red lines indicate the mean.
(C) Expression of endogenous p53 or the p53 reporter is uniformly increased after damage. Images: MCF7 cells expressing p53-YFP were imaged before and
after (2 hr) DNA damage. Histograms: distribution of endogenous p53 quantified by immunofluorescence. The red lines indicate the mean.
(legend continued on next page)
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In response to DNAdamage, there is substantial heterogeneity
in the accumulation of CDKN1A, which we find to be a conse-
quence of post-translational regulation, as is largely explained
by cell-cycle position at the moment of damage. The delayed
CDKN1A accumulation in S-phase damaged cells is intriguing,
as cells in the Sphase have long been known to bemore resistant
to DNA damage (Griffith and Tolmach, 1976). This has largely
been presumed to be due to pre-adapted repair machinery.
Low CDKN1A expression—and, thus, no firm block of cell-cycle
progression when the cell eventually exits the S phase—could
also provide a proliferative advantage. Consistent with this hy-
pothesis, we observed that cells inducing CDKN1A within 5 hr
of DNA damage show decreased proliferation 24 hr later. The
eFlut toolset we present herewill enable the construction of addi-
tional reporters in diverse cell lines to further explore the relation-
ship between cell-cycle phase and resistance to DNA damage.
EXPERIMENTAL PROCEDURES
Cell Culture
Parental cell lines were generally obtained from ATCC, thawed, and propa-
gated in RPMI (GIBCO) with 5% fetal bovine serum (FBS) or DMEM with
10% fetal calf serum (FCS) (NIH 3T3). For microscopy, RPMI lacking phenol
red and riboflavin was used. MDCK cells were obtained from the Harvard
Digestive Disease Center. HEPA1C1C7 was a gift from Dr. Charles Weitz, Har-
vardMedical School. Cells were transfected using LT1 reagent (Mirus) accord-
ing to the manufacturer’s instructions. Single-cell clones were obtained by
limiting dilution.
Gene Tagging
See the Supplemental Experimental Procedures for detailed protocol. Briefly,
cells were transfected with a cocktail of PCR-produced homology donor and a
Cas9 plasmid expressing a gRNA directed at the locus of interest. In the case
of multi-color tagging (Figure 2G), two separate donor sequences (different co-
lor proteins with the same antibiotic) were mixed at a 1:1 ratio and transfected.
Cells were allowed to recover from the transfection and recombine before se-
lection with the appropriate antibiotic. Selected populations were then used as
a polyclonal mixture or selected for single clones by limiting dilution.
Chemical Treatments
DNA damage was inflicted by addition of the radiomimetic drug (NCS (Sigma)
at 100 ng/ml. Nutlin3A was purchased from Sigma, dissolved in DMSO, and
applied at a final concentration of 5 mM for the indicated times. Other small-
molecule inhibitors used in Figure 3 were applied and assayed at the following
concentrations and times: TNFa (10 ng/ml; 30 min; Sigma), AZD8055 (100 nM,
10 min; Biovision), and CH99021 (5 mM, 30 min; Sigma). Doxycycline (Sigma)
was applied at 1 mg/ml to induce the Tet-NSLMB construct.
Antibodies and Reagents
Primary antibodies for CDKN1A (Calbiochem), p53 (FL393, Santa Cruz Biotech-
nology), and GFP (Invitrogen) were purchased and used at 1:400–800. Second-(D) The CDKN1A transcriptional reporter (1B) was measured in live (images) or fix
DNA damage. The red lines indicate the mean.
(E) MCF7 cells were fixed before and 2 hr after DNA damage by NCS. CDKN1A m
increase after DNA damage.
(F) MCF7 cells expressing the CDKN1A fusion (plasmid 1A) or the transcriptional re
of each). Faint lines represent example traces from single cells. Bold lines repres
thereafter declines slowly, CDKN1A proteins levels rise gradually and heterogen
(G) CDKN1A levels in cells 4 hr after DNA damage were plotted against the las
expected to be in the S phase.
(H) The box-and-whisker plot diagram of the data presented in (G) reveals that CD
for cells in the S phase.
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were purchased from Invitrogen. DAPI was purchased from Life Technologies.
Plasmids and Cloning
Standard molecular biology techniques using restriction-enzyme-based clon-
ing were applied to construct template plasmids. Homology donors were
amplified from templates with Phusion DNA Polymerase (New England Bio-
labs) and gel purified. Briefly, fluorescent proteins with a 10AA GA linker
were amplified and cloned into a kanamycin-marked shuttle vector’s multiple
cloning site with Xho1/EcoR1. Subsequently, P2A-selection marker se-
quences were amplified and cloned into EcoR1 and Sac1 of the same vector.
For XFP-NLS-PEST, the sequence was amplified and cloned into the same
vector with a Sal1/EcoR1 digestion (destroying the Xho1 site; this was neces-
sary as the PEST sequence contained a Xho1 site). The N-terminal-tagging
plasmid vector was constructed similarly, with Neo cloned between Xho1/
EcoR1 and T2A-EGFP cloned between EcoR1 and Sac1.
Our Cas9 expression plasmid (pSpCas9(BB)-2A-Puro (PX459)) was a
gift from Dr. Feng Zhang (Addgene plasmid #48139). The GFP degrada-
tion construct was constructed by amplifying NSlmb-vhhGFP4 from
pcDNA3_NSlmb-vhhGFP4 plasmid, which was a gift from Dr. Markus Affolter
(Addgene plasmid #35579), and cloning it into a doxycycline-inducible vector.
The pRetroSuper-p53sh vector was a gift fromDr. Reuven Agami (Netherlands
Cancer Institute; NKI). Oligos were ordered from Integrated DNA Technologies
(sequences are in Table S1).
Virus Production and Infection
Virus was produced using 293T cells transfected with p53shRNA, GMNN(1-
110)-CFP,orp53-YFPconstructs andviral packagingvectors. Viral supernatant
was collected after 3 days. For viral infection, MCF7 cells were plated at low
density, and cells were infectedwith virus inmedia containingHEPES and prot-
amine sulfate. Cells were allowed to recover in nonselective media for 1 day.
Cells productively infected were selected with the appropriate antibiotic.
Microscopy
Cells were plated in glass-bottom 35-mm dishes (MatTek) 24–48 hr before im-
aging; 1–2 hr before imaging, cells were switched to transparent media (RPMI
lacking riboflavin and phenol red; Invitrogen). Live-cell imaging was performed
with a Nikon Eclipse Ti-E microscope equipped with a heating chamber (37C)
and CO2 control (5%); an epi-fluorescent source (either mercury arc lamp
[Prior] or LED system [Lumencor]), automated stage (Prior); YFP, mCherry,
or CFP filter set (Chroma); and a charge-coupled device (CCD) or complemen-
tary metal-oxide-semiconductor (CMOS) camera (Hamamatsu). All live-cell
imaging was performed with a 203 PA objective (Nikon).
Immunofluorescence
Cells were plated in 35-mm dishes on glass coverslips; at the appropriate time
after treatment, they were fixed with 2% formaldehyde (Alfa Aesar) for 10 min
at room temperature, followed by permeabilization with 0.1% Triton (EMD).
Cells were sequentially stained with antibodies for CDKN1A, TP53, or GFP,
and secondary antibodies conjugated to Alexa Fluor 647 or Alexa Fluor 555.
Cells were imaged on a Nikon Eclipse Ti-E microscope equipped with an
epi-fluorescent source (Prior); an automated stage (Prior); YFP, Cy3, or Cy5 fil-
ter sets (Chroma); and a CCD camera (Hamamatsu).ed (histograms) cells and, like p53, shows uniform increase in expression after
RNA was measured by smFISH. The mRNA levels of CDKN1A show a uniform
porter (plasmid 1B) were tracked for 24 hr before and after DNA damage (n = 20
ent the average traces. While the transcriptional tag is rapidly expressed and
eously.
t time that each cell divided (div) (n = 153), showing a trough where cells are
KN1A levels rise for cells in the G1 andG2 stages at the time of damage, but not
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Figure 6. CDKN1A Accumulation Predicts Loss of Proliferation in
Response to DNA Damage
(A) Cells expressing the proliferationmarker ki67-YFP andCDKN1A-RFP show
primarily ki67 expression in an untreated culture and substantial CDKN1A-RFP
expression after DNA damage (24 hr after NCS).
Cell RImmunoblotting
Cells were harvested and protein extracts obtained by lysis in the presence of
protease and phosphatase inhibitors. Total protein amount was quantified us-
ing the Bradford assay (Invitrogen) and transferred to nitrocellulose mem-
branes by electroblotting. Membranes were blocked with 5% non-fat dried
milk, incubated with primary antibody, washed, and incubated with secondary
antibody coupled to IR800 or IR680 dyes (LI-COR Biosciences). Protein levels
were detected using an Odyssey scanner (LI-COR Biosciences).
smFISH
Cells were fixed with 2% formaldehyde for 10 min, followed by treatment with
75% ethanol at 4C. smFISHwas performed using a previously described pro-
tocol (Raj et al., 2008; Purvis et al., 2012). Probes for CDKN1Awere purchased
from Biosearch Technologies. Hybridization was at 37C for 4 hr, and washing
conditions were 23 30 min at 37C, 10% formamide. We acquired 15–25 focal
planes at 0.2-mM intervals using MetaMorph acquisition software (Molecular
Devices). Typical exposure times per individual focal plane were 0.2 s. Gene
expression was quantified by counting cytoplasmic intensity above a given
threshold at 603 magnification.
Selection of gRNAs
Wedownloaded the human genome sequence fromNCBI and used Reference
Sequence (RefSeq) transcript data to define the C terminus of each ORF. Po-
tential gRNA sequences with cut sites within 20 bp of the stop codon were
examined for GC content, uniqueness in the genome, nearness to the stop
codon, and lack of polyN sequences. A gRNA was selected for each gene
and cloned into the Cas9 vector (see Table S1 for sequences). Note that
gRNAsmay cut the genome inmultiple locations, leading to additional non-tar-
geted integrations.
Selection of Homology Regions
We selected 40 bp immediately before and after the stop codon as our homol-
ogy regions. In situations in which the gRNA cut site would be retained in the
recombined sequence, we introduced silent mutations to eliminate the gRNA
protospacer adjacent motif (PAM) site or one of the first five nucleotides in its
recognition region (see Table S1 for sequences).
Microscopy Data Analysis
Microscopy data (live and fixed) were processed with custom MATLAB code.
Single cells were tracked manually, using the phase images with a MATLAB
interface. Single-cell tracks were projected onto the fluorescent images, which
were then background corrected (by median filtering and subsequent Top-hat
background subtraction), and nuclear signal (estimated as the average of the
top ten pixels in the nuclear area) was then computed for the applicable chan-
nels. Fixed images were segmented using the DAPI channel with a watershed
algorithm, andmean nuclear intensity was computed for each cell. Images dis-
played in the body of the paper were smoothedwith amedian or Gaussian filter
and background subtracted. Contrast was adjusted for optimal visualization
and is consistent between pre- and post-treatment for all images.
Cell-Cycle Analysis and In Silico Alignment
To study the influence of the cell cycle on CDKN1A accumulation, we
measured single-cell trajectories of CDKN1A (or p53) and also noted the timing
of mitosis in each cell. Then, we computationally aligned each trajectory to the
first mitosis. This analysis results in a computationally synchronized population
to study cell-cycle-regulated protein signaling.(B) Single-cell traces of CDKN1A-RFP and ki67-YFP after DNA damage show
gain of CDKN1A-RFP and loss of ki67-YFP.
(C) The levels of CDKN1A-RFP and ki67-YFP are plotted at the indicated time
points after DNA damage, showing largely exclusive staining patterns with
a gradual accumulation of CDKN1A-RFP and loss of ki67-YFP cells over time
(n > 1,000 cells per time point).
(D) CDKN1A expression predicts subsequent loss of ki67-YFP. Cells that show
accumulation of CDKN1A-RFP relative to time 0 (CDKN1A+ cells) show sub-
stantially lower ki67-YFP expression at 24 hr. n = 255.
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